ELECTROLYTE FOR AQUEOUS ZINC-BROMINE BATTERY CONTAINING BROMINE COMPLEXING AGENT AND METAL ION ADDITIVE, AND AQUEOUS ZINC-BROMINE NON-FLOW BATTERY CONTAINING SAME
20240021887 ยท 2024-01-18
Inventors
- Hyeong-Jin Kim (Gwangju, KR)
- Hyeonghun PARK (Gwangju, KR)
- Santosh KUMAR (Gwangju, KR)
- Geumyong PARK (Gwangju, KR)
- Hyunsu KIM (Gwangju, KR)
- Juyeon BAEK (Gwangju, KR)
- Seokho SUH (Gwangju, KR)
- Hocheol YOON (Gwangju, KR)
Cpc classification
International classification
Abstract
Provided is an electrolyte including a bromine complexing agent and a metal ion additive. The electrolyte is prepared by inputting zinc bromide (ZnBr.sub.2) salt, a bromine complexing agent, and a metal ion additive containing Mn to DI water. The bromine complexing agent prevents a crossover phenomenon by capturing bromine to alleviate self-discharge at a positive electrode, and the metal ion additive inhibits the formation of zinc dendrites on a negative electrode through an electrostatic shielding effect. Accordingly, battery performance may be improved by a synergistic effect generated in a positive electrode and a negative electrode by the bromine complexing agent and the metal ion additive.
Claims
1. An electrolyte for a zinc-bromine aqueous battery, comprising: zinc bromide (ZnBr.sub.2) salt, a bromine complexing agent, and a metal ion additive.
2. The electrolyte of claim 1, wherein the bromine complexing agent is one or more selected from the group consisting of 1-ethylpyridinium bromide ([C.sub.2Py]Br,1-EpBr), 1-methylpyrrolidin-1-ium hydrobromide ([HMP]Br), 1-ethyl-1-methylpyrrolidin-1-iumbromide ([C.sub.2MP]Br)(=[MEP]Br), 1-n-butyl-1-methylpyrrolidin-1-iumbromide ([C.sub.4MP]Br), 1-n-hexyl-1-methylpyrrolidin-1-iumbromide ([C.sub.6MP]Br), 1-ethyl-1-methylmorpholin-1-iumbromide ([C.sub.2MM]Br)(=[MEM]Br), 1-n-butyl-1-methylmorpholin-1-iumbromide ([C.sub.4MM]Br), pyridin-1-ium hydrobromide ([HPy]Br), 1-n-butylpyridin-1-iumbromide ([C.sub.4Py]Br), 1-n-butylpyridin-1-iumchloride ([C.sub.4Py]Cl), 1-n-hexylpyridin-1-iumbromide ([C.sub.6Py]Br), 1-n-hexylpyridin-1-iumchloride ([C.sub.6Py]Cl), 4-methylpyridine hydrobromide ([H.sub.4MPy]Br), 1-ethyl-4-methylpyridine hydrobromide ([C.sub.24MPy]Br), 1-n-butyl-4-methylpyridine hydrobromide ([C.sub.44MPy]Br), 1-n-hexyl-4-methylpyridine hydrobromide ([C.sub.23MPy]Br), 3-methylpyridine hydrobromide ([H.sub.3MPy]Br), 1-ethyl-3-methylpyridinebromide ([C.sub.23MPy]Br), 1-n-butyl-3-methyl-pyridinebromide ([C.sub.43MPy]Br), 1-n-hexyl-3-methyl-pyridinebromide ([C.sub.63MPy]Br), 3-methylimidazol-1-ium hydrobromide ([HMIm]Br), 1-ethyl-3-methylimidazol-1-iumbromide ([C.sub.2MIm]Br), 1-ethyl-3-methylimidazol-1-iumchloride ([C.sub.2MIm]Cl), 1-n-propyl-3-methylimidazol-1-iumbromide ([C.sub.3MIm]Br), 1-n-butyl-3-methyl-imidazol-1-iumbromide ([C.sub.4MIm]Br), 1-n-butyl-3-methyl-imidazol-1-iumchloride ([C.sub.4MIm]Cl), 1-n-hexyl-3-methylimidazol-1-iumbromide ([C.sub.6MIm]Br), 1-n-hexyl-3-methylimidazol-1-iumchloride ([C.sub.6MIm]Cl), 1-methylpiperidin hydrobromide ([HMPip]Br), 1-ethyl-1-methylpiperidinbromide ([C.sub.2MPip]Br), 1-n-butyl-1-methylpiperidinbromide ([C.sub.4MPip]Br), 1-n-hexyl-1-methylpiperidinbromide ([C.sub.6MPip]Br), 1,1,1-trimethyl-1-n-tetradecyl ammoniumbromide ([MTA]Br), 1,1,1-trimethyl-1-n-hexadecyl ammoniumbromide ([CTA]Br), tetraethylammoniumbromide ([TEA]Br), tetra-n-butylammoniumbromide ([TBA]Br), tetra-n-octylammoniumbromide ([TOA]Br), tetra-n-octylammoniumchloride ([TOA]Cl), (polysorbate).sub.n-1R.sub.1-2R.sub.2-3R.sub.3 imidazolium bromide, and (polysorbate).sub.n-1R.sub.1-3R.sub.3 imidazolium bromide, wherein each of R1, R2 and R3 independently has a functional group with 1 to 4 carbon atoms.
3. The electrolyte of claim 1, wherein the bromine complexing agent has a molarity of 0.1 M to 1.5 M.
4. The electrolyte of claim 1, wherein the metal ion additive has a lower standard reduction potential than the standard reduction potential of zinc, and a higher standard oxidation potential than the standard oxidation potential of bromine.
5. The electrolyte of claim 1, wherein the metal ion additive is a salt containing Mn.
6. The electrolyte of claim 5, wherein the metal ion additive is one selected from the group consisting of MnSO.sub.4, MnCl.sub.2, Mn(NO.sub.3).sub.2, Mn.sub.3(PO.sub.4).sub.2, and Mn(CH.sub.3CO.sub.2).sub.2.
7. The electrolyte of claim 1, wherein the metal ion additive has a molarity of 0.05 M to 0.1 M.
8. The electrolyte of claim 1, wherein the ZnBr.sub.2 has a molarity of 2.0 M to 3.0 M.
9. An aqueous zinc-bromine non-flow battery, comprising: a negative electrode in which a zinc metal layer is formed on a negative electrode conductive plate and zinc reduction occurs during a charging operation; a positive electrode in which carbon felt is formed on a positive electrode conductive plate and bromine oxidation occurs during a charging operation; and an electrolyte charged in a space between the negative electrode and the positive electrode, wherein the electrolyte comprises ZnBr.sub.2, a bromine complexing agent, and a metal ion additive.
10. The battery of claim 9, wherein the positive electrode comprises bromine captured on the carbon graphite felt by the bromine complexing agent during the charging operation.
11. The battery of claim 9, wherein the bromine complexing agent is one or more selected from the group consisting of 1-ethylpyridinium bromide ([C.sub.2Py]Br,1-EpBr), 1-methylpyrrolidin-1-ium hydrobromide ([HMP]Br), 1-ethyl-1-methylpyrrolidin-1-iumbromide ([C.sub.2MP]Br)(=[MEP]Br), 1-n-butyl-1-methylpyrrolidin-1-iumbromide ([C.sub.4MP]Br), 1-n-hexyl-1-methylpyrrolidin-1-iumbromide ([C.sub.6MP]Br), 1-ethyl-1-methylmorpholin-1-iumbromide ([C.sub.2MM]Br)(=[MEM]Br), 1-n-butyl-1-methylmorpholin-1-iumbromide ([C.sub.4MM]Br), pyridin-1-ium hydrobromide ([HPy]Br), 1-n-butylpyridin-1-iumbromide ([C.sub.4Py]Br), 1-n-butylpyridin-1-iumchloride ([C.sub.4Py]Cl), 1-n-hexylpyridin-1-iumbromide ([C.sub.6Py]Br), 1-n-hexylpyridin-1-iumchloride ([C.sub.6Py]Cl), 4-methylpyridine hydrobromide ([H.sub.4MPy]Br), 1-ethyl-4-methylpyridine hydrobromide ([C.sub.24MPy]Br), 1-n-butyl-4-methylpyridine hydrobromide ([C.sub.44MPy]Br), 1-n-hexyl-4-methylpyridine hydrobromide ([C.sub.23MPy]Br), 3-methylpyridine hydrobromide ([H.sub.3MPy]Br), 1-ethyl-3-methylpyridinebromide ([C.sub.23MPy]Br), 1-n-butyl-3-methyl-pyridinebromide ([C.sub.43MPy]Br), 1-n-hexyl-3-methyl-pyridinebromide ([C.sub.63MPy]Br), 3-methylimidazol-1-ium hydrobromide ([HMIm]Br), 1-ethyl-3-methylimidazol-1-iumbromide ([C.sub.2MIm]Br), 1-ethyl-3-methylimidazol-1-iumchloride ([C.sub.2MIm]Cl), 1-n-propyl-3-methylimidazol-1-iumbromide ([C.sub.3MIm]Br), 1-n-butyl-3-methyl-imidazol-1-iumbromide ([C.sub.4MIm]Br), 1-n-butyl-3-methyl-imidazol-1-iumchloride ([C.sub.4MIm]Cl), 1-n-hexyl-3-methylimidazol-1-iumbromide ([C.sub.6MIm]Br), 1-n-hexyl-3-methylimidazol-1-iumchloride ([C.sub.6MIm]Cl), 1-methylpiperidin hydrobromide ([HMPip]Br), 1-ethyl-1-methylpiperidinbromide ([C.sub.2MPip]Br), 1-n-butyl-1-methylpiperidinbromide ([C.sub.4MPip]Br), 1-n-hexyl-1-methylpiperidinbromide ([C.sub.6MPip]Br), 1,1,1-trimethyl-1-n-tetradecyl ammoniumbromide ([MTA]Br), 1,1,1-trimethyl-1-n-hexadecyl ammoniumbromide ([CTA]Br), tetraethylammoniumbromide ([TEA]Br), tetra-n-butylammoniumbromide ([TBA]Br), tetra-n-octylammoniumbromide ([TOA]Br), tetra-n-octylammoniumchloride ([TOA]Cl), (polysorbate).sub.n-1R.sub.1-2R.sub.2-3R.sub.3 imidazolium bromide, and (polysorbate).sub.n-1R.sub.1-3R.sub.3 imidazolium bromide, wherein each of R1, R2 and R3 independently has a functional group with 1 to 4 carbon atoms.
12. The battery of claim 9, wherein the negative electrode inhibits zinc dendrite formation by capping the surface of a surface protrusion of a zinc metal layer with the metal ion additive.
13. The battery of claim 9, wherein the metal ion additive has a lower standard reduction potential than the standard reduction potential of zinc, and a higher standard oxidation potential than the standard oxidation potential of bromine.
14. The battery of claim 9, wherein the metal ion additive is a salt containing Mn.
15. The battery of claim 9, wherein the metal ion additive is one selected from the group consisting of MnSO.sub.4, MnCl.sub.2, Mn(NO.sub.3).sub.2, Mn.sub.3(PO.sub.4).sub.2, and Mn(CH.sub.3CO.sub.2).sub.2.
Description
BRIEF DESCRIPTION OF DRAWINGS
[0010] Example embodiments of the present inventive concept will become more apparent by describing in detail example embodiments of the present inventive concept with reference to the accompanying drawings, in which:
[0011]
[0012]
[0013]
[0014]
[0015]
[0016]
[0017]
[0018]
[0019]
[0020]
[0021]
[0022]
DESCRIPTION OF EXAMPLE EMBODIMENTS
[0023] While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that there is no intent to limit the invention to the particular forms disclosed, but on the contrary, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
[0024] Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
[0025] Hereinafter, example embodiments of the present inventive concept will be described in further detail with reference to the accompanying drawings.
First Embodiment
[0026]
[0027] The bromine complexing agent is one or more selected from the group consisting of 1-ethylpyridinium bromide ([C.sub.2Py]Br,1-EpBr), 1-methylpyrrolidin-1-ium hydrobromide ([HMP]Br), 1-ethyl-1-methylpyrrolidin-1-iumbromide ([C.sub.2MP]Br)(=[MEP]Br), 1-n-butyl-1-methylpyrrolidin-1-iumbromide ([C.sub.4MP]Br), 1-n-hexyl-1-methylpyrrolidin-1-iumbromide ([C.sub.6MP]Br), 1-ethyl-1-methylmorpholin-1-iumbromide ([C.sub.2MM]Br)(=[MEM]Br), 1-n-butyl-1-methylmorpholin-1-iumbromide ([C.sub.4MM]Br), pyridin-1-ium hydrobromide ([HPy]Br), 1-n-butylpyridin-1-iumbromide ([C.sub.4Py]Br), 1-n-butylpyridin-1-iumchloride ([C.sub.4Py]Cl), 1-n-hexylpyridin-1-iumbromide ([C.sub.6Py]Br), 1-n-hexylpyridin-1-iumchloride ([C.sub.6Py]Cl), 4-methylpyridine hydrobromide ([H.sub.4MPy]Br), 1-ethyl-4-methylpyridine hydrobromide ([C.sub.24MPy]Br), 1-n-butyl-4-methylpyridine hydrobromide ([C.sub.44MPy]Br), 1-n-hexyl-4-methylpyridine hydrobromide ([C.sub.23MPy]Br), 3-methylpyridine hydrobromide ([H.sub.3MPy]Br), 1-ethyl-3-methylpyridinebromide ([C.sub.23MPy]Br), 1-n-butyl-3-methyl-pyridinebromide ([C.sub.43MPy]Br), 1-n-hexyl-3-methyl-pyridinebromide ([C.sub.63MPy]Br), 3-methylimidazol-1-ium hydrobromide ([HMIm]Br), 1-ethyl-3-methylimidazol-1-iumbromide ([C.sub.2MIm]Br), 1-ethyl-3-methylimidazol-1-iumchloride ([C.sub.2MIm]Cl), 1-n-propyl-3-methylimidazol-1-iumbromide ([C.sub.3MIm]Br), 1-n-butyl-3-methyl-imidazol-1-iumbromide ([C.sub.4MIm]Br), 1-n-butyl-3-methyl-imidazol-1-iumchloride ([C.sub.4MIm]Cl), 1-n-hexyl-3-methylimidazol-1-iumbromide ([C.sub.6MIm]Br), 1-n-hexyl-3-methylimidazol-1-iumchloride ([C.sub.6MIm]Cl), 1-methylpiperidin hydrobromide ([HMPip]Br), 1-ethyl-1-methylpiperidinbromide ([C.sub.2MPip]Br), 1-n-butyl-1-methylpiperidinbromide ([C.sub.4MPip]Br), 1-n-hexyl-1-methylpiperidinbromide ([C.sub.6MPip]Br), 1,1,1-trimethyl-1-n-tetradecylammoniumbromide ([MTA]Br), 1,1,1-trimethyl-1-n-hexadecylammoniumbromide ([CTA]Br), tetraethylammoniumbromide ([TEA]Br), tetra-n-butylammoniumbromide ([TBA]Br), tetra-n-octylammoniumbromide ([TOA]Br), tetra-n-octylammoniumchloride ([TOA]Cl), (polysorbate).sub.n-1R.sub.1-2R.sub.2-3R.sub.3 imidazolium bromide, and (polysorbate).sub.n-1R.sub.1-3R.sub.3 imidazolium bromide, in which each of R1, R2 and R3 independently has a functional group with 1 to 4 carbon atoms. As the bromine complexing agent, 1-EpBr is preferably used. As the 1-EpBr forms a complex with bromine to allow bromine to remain in the carbon graphite felt 40, a crossover phenomenon in which bromine in an electrolyte moves to a negative electrode is inhibited without a membrane. Since the crossover phenomenon is inhibited, dendrite formation caused by the reaction of bromine and zinc and self-discharge may be prevented.
[0028] The bromine complexing agent may have a molarity of 0.1 to 1.5 M, preferably 0.1 to 1.0 M. The molarity of the bromine complexing agent is more preferably 0.1 to 0.6 M, and even more preferably 0.4 to 0.6 M. When the molarity is less than 0.1 M, bromine may not be properly captured, and when the molarity is more than 1.5 M, as the concentration increases, the ionic conductivity in the electrolyte decreases, and thus the bromine concentration in the electrolyte becomes excessively low. Accordingly, battery performance may not be good.
[0029] The metal ion additive may induce an electrostatic shielding phenomenon on the surface of a zinc electrode.
[0030] The metal ion additive preferably includes metal ions having a standard reduction potential of less than 0.76 V and a standard oxidation potential of more than 1.08 V.
Br.sub.2+2e.sup..Math.2Br.sup.
Zn.sup.2++2e.sup..Math.Zn[Formula 1]
[0031] The standard oxidation potential of bromine in Formula 1 is 1.08 V, and the standard reduction potential of zinc in Formula 1 is 0.76 V. Accordingly, the metal ions of the metal ion additive have to be materials that do not cause redox reactions at 0.76 V to 1.08 V to prevent a battery from reacting during battery operation. Metal ions satisfying the condition outside the range of 0.76 V to 1.08 V are lithium, sodium, potassium, and manganese. Although chromium is a metal ion having the same cycle as potassium and manganese, it is not suitable for use as a metal ion additive because it is reduced from Cr.sup.3+ to Cr.sup.2+ at approximately 0.407 V within the above range. When chromium is used as a metal ion additive, compared to the case in which only ZnBr.sub.2 is used as an electrolyte, or 1-EpBr is additionally included, the voltage rapidly decreased after approximately 45 hours of discharging. Accordingly, it is difficult to use chromium as a metal ion additive because self-discharge is induced by a reaction of chromium in a battery over time and thus the voltage drops greatly.
[0032] The metal ion additive preferably includes Mn, and is one selected from the group consisting of MnSO.sub.4, MnCl.sub.2, Mn(NO.sub.3).sub.2, Mn.sub.3(PO.sub.4).sub.2, and Mn(CH.sub.3CO.sub.2).sub.2. More preferably, as the metal ion additive, MnSO.sub.4 is used. The standard reduction potential of Mn.sup.2+ is approximately 1.18 V, which is not included in the above range, and the standard oxidation potential of Mn.sup.2+ is approximately 1.4 V, which is not included in the above range. When a metal ion additive including manganese is used, compared to metal ion additives including lithium sodium and potassium, fewer dendrites are formed, and excellent coulombic efficiency is obtained up to 700 cycles.
[0033] The metal ion additive may have a molarity of 0.05 M to 0.1 M, preferably 0.05 M. When the molarity of the metal ion additive is less than 0.05 M or more than 0.1 M, the performance of the battery may not be excellent because the coulombic efficiency drops below 90%.
[0034] The molarity of ZnBr.sub.2 may be 2.0 M to 3.0 M, and preferably 2.25 M to 2.8 M. When the molarity of ZnBr.sub.2 is less than 2.0 M, it is disadvantageous in terms of energy density because the amount of an active material in the electrolyte is reduced. In addition, since the salt concentration in the electrolyte is lowered, ionic conductivity is lowered. When the molarity of ZnBr.sub.2 exceeds 3.0 M, the pH of the electrolyte decreases, so a hydrogen evolution reaction (HER) becomes active. Accordingly, the pressure in a cell increases due to hydrogen generated in the cell, causing the problem of an insufficient electrolyte.
Preparation Example 1
[0035] An electrolyte was prepared by inputting 2.25 M ZnBr.sub.2, 0.1 M 1-EpBr and 0.5 M MnSO.sub.4 to DI water and stirring the resulting solution for 1 hour.
Preparation Example 2
[0036] An electrolyte was prepared by inputting 2.25 M ZnBr.sub.2 and 0.1 M 1-EpBr to DI water and stirring the resulting solution for 1 hour.
Preparation Example 3
[0037] An electrolyte was prepared by inputting 2.25 M ZnBr.sub.2, 0.1 M 1-EpBr, and 0.05 M MnSO.sub.4 to DI water and stirring the resulting solution for 1 hour.
Preparation Example 4
[0038] An electrolyte was prepared by inputting 2.25 M ZnBr.sub.2 and 0.05 M MnSO.sub.4 to DI water and stirring the resulting solution for 1 hour.
Preparation Example 5
[0039] An electrolyte was prepared by inputting 2.25 M ZnBr.sub.2, 0.1 M 1-EpBr, and 0.1 M MnSO.sub.4 to DI water and stirring the resulting solution for 1 hour.
Preparation Example 6
[0040] An electrolyte was prepared by inputting 2.8 M ZnBr.sub.2 and 0.1 M 1-EpBr to DI water and stirring the resulting solution for 1 hour.
Preparation Example 7
[0041] An electrolyte was prepared by inputting 2.8 M ZnBr.sub.2 and 0.2 M 1-EpBr to DI water and stirring the resulting solution for 1 hour.
Preparation Example 8
[0042] An electrolyte was prepared by inputting 2.8 M ZnBr.sub.2 and 0.3 M 1-EpBr to DI water and stirring the resulting solution for 1 hour.
Preparation Example 9
[0043] An electrolyte was prepared by inputting 2.8 M ZnBr.sub.2 and 0.4 M 1-EpBr to DI water and stirring the resulting solution for 1 hour.
Preparation Example 10
[0044] An electrolyte was prepared by inputting 2.8 M ZnBr.sub.2 and 0.5 M 1-EpBr to DI water and stirring the resulting solution for 1 hour.
Preparation Example 11
[0045] An electrolyte was prepared by inputting 2.8 M ZnBr.sub.2 and 0.6 M 1-EpBr to DI water and stirring the resulting solution for 1 hour.
Preparation Example 12
[0046] An electrolyte was prepared by inputting 2.8 M ZnBr.sub.2, 0.5 M 1-EpBr, and 0.05 M MnSO.sub.4 to DI water and stirring the resulting solution for 1 hour.
Preparation Example 13
[0047] An electrolyte was prepared by inputting 2.8 M ZnBr.sub.2, 0.5 M 1-EpBr, and 0.1 M MnSO.sub.4 to DI water and stirring the resulting solution for 1 hour.
Preparation Example 14
[0048] An electrolyte was prepared by inputting 2.8 M ZnBr.sub.2, 0.5 M 1-EpBr, and 0.2 M MnSO.sub.4 to DI water and stirring the resulting solution for 1 hour.
Comparative Example 1
[0049] An electrolyte was prepared by inputting 2.25 M ZnBr.sub.2 to DI water and stirring the resulting solution for 1 hour.
Comparative Example 2
[0050] An electrolyte was prepared by inputting 2.25 M ZnBr.sub.2, 0.1 M 1-EpBr, and 0.025 M Na.sub.2SO.sub.4 to DI water and stirring the resulting solution for 1 hour.
Comparative Example 3
[0051] An electrolyte was prepared by inputting 2.25 M ZnBr.sub.2, 0.1 M 1-EpBr, and 0.025 M Li.sub.2SO.sub.4 to DI water and stirring the resulting solution for 1 hour.
Comparative Example 4
[0052] An electrolyte was prepared by inputting 2.25 M ZnBr.sub.2, 0.1 M 1-EpBr, and 0.025 M KaSO.sub.4 to DI water and stirring the resulting solution for 1 hour.
Comparative Example 5
[0053] An electrolyte was prepared by inputting 2.25 M ZnBr.sub.2 and 0.05 M CrCl.sub.3 to DI water and stirring the resulting solution for 1 hour.
Comparative Example 6
[0054] An electrolyte was prepared by inputting 2.25 M ZnBr.sub.2, 0.1 M 1-EpBr, and 0.05 M CrCl.sub.3 to DI water and stirring the resulting solution for 1 hour.
Experimental Example 1
[0055] Experiments were performed by preparing unit cells including electrolytes of Preparation Examples 1 to 14 and Comparative Examples 1 to 6, respectively. In the unit cell, a current collector was placed on the end plate, the positive electrode was placed on the current collector, a chamber including the electrolyte was placed on the positive electrode, and a negative electrode were disposed in a symmetrical structure based on the chamber and fastened. The positive electrode used herein is 4T graphite felt, and the negative electrode is 0.25 T Zn foil.
[0056]
Experimental Example 2
[0057]
TABLE-US-00001 TABLE 1 Average coulombic Classification Electrolyte efficiency Comparative Example 1 2.25M ZnBr.sub.2 88.1% Preparation Example 2 +0.1M 1-EpBr 98.9% Preparation Example 3 +0.1M 1-EpBr 99.4% +0.05M MnSO.sub.4
[0058] Table 1 shows the values of average coulombic efficiency according to the type of electrolyte. Comparative Example 1 which does not include 1-EpBr as a bromine complexing agent and MnSO.sub.4 as a metal ion additive has an average coulombic efficiency of 88.1%, which is the lowest among Comparative Example 1, Preparation Example 2 and Preparation Example 3, and becomes irreversible due to dendrites formed at approximately 100 cycles. In contrast, Preparation Examples 2 and 3 maintain coulombic efficiency for 300 cycles or more, and exhibit excellent performance with an average coulombic efficiency of 98% or more. In Preparation Example 2 in which 1-EpBr as a bromine complexing agent is added, dendrites start to form after 200 cycles, resulting in a decrease in coulombic efficiency. However, in Preparation Example 3 in which MnSO.sub.4 as a metal ion additive is added, MnSO.sub.4 induces the electrodeposition and release of zinc to inhibit dendrite formation and prevent decreased coulombic efficiency, resulting in improving electrochemical performance.
Experimental Example 3
[0059]
[0060]
[0061]
Experimental Example 4
[0062]
TABLE-US-00002 TABLE 2 Average Average coulombic voltage Classification Electrolyte efficiency efficiency Preparation Example 2 +0.1M 1-EpBr 98.9% 67.7% Preparation Example 3 +0.1M 1-EpBr 99.4% 67.4% +0.05M MnSO.sub.4 Preparation Example 5 +0.1M 1-EpBr 98.7% 65.5% +0.1M MnSO.sub.4
[0063] Referring to
[0064] Referring to
Experimental Example 5
[0065]
TABLE-US-00003 TABLE 3 Average coulombic Classification Electrolyte efficiency Preparation Example 6 +0.1M 1-EpBr 88.1% Preparation Example 7 +0.2M 1-EpBr 91.4% Preparation Example 8 +0.3M 1-EpBr 94.5% Preparation Example 9 +0.4M 1-EpBr 96.12% Preparation Example 10 +0.5M 1-EpBr 96.38% Preparation Example 11 +0.6M 1-EpBr 92.3%
[0066] Referring to Table 3, the coulombic efficiency of Preparation Example 10 is the highest at 96.38%. Accordingly, a preferable 1-EpBr concentration according to the average coulombic efficiency is 0.1 M to 0.6 M. However, when 1-EpBr is used alone, referring to
Experimental Example 6
[0067]
TABLE-US-00004 TABLE 4 Coulombic efficiency Classification Electrolyte (based on 50 cycles) Preparation Example 10 +0.5M 1-EpBr 89.2% Preparation Example 12 +0.5M 1-EpBr 96.3% +0.05M MnSO.sub.4 Preparation Example 13 +0.5M 1-EpBr 96.4% +0.1M MnSO.sub.4 Preparation Example 14 +0.5M 1-EpBr 94.0% +0.2M MnSO.sub.4
[0068] Referring to Table 4, MnSO.sub.4 has a coulombic efficiency of 90% or more in Preparation Examples 12 and 13. Compared to Experimental Example 4, as the current density decreases from 20 mAcm.sup.2 to 10 mAcm.sup.2, and the electrostatic repulsion force decreases, and thus in Preparation Example 13 including 0.1 M MnSO.sub.4, excellent coulombic efficiency is shown. In addition, referring to
[0069] Accordingly, under the above conditions, the optimal concentration range of MnSO.sub.4 in an electrolyte is 0.05 M to 0.1 M, and the performance of Preparation Example 13 is the highest.
[0070] As the present inventive concept uses a metal ion additive, an electrostatic shielding phenomenon may occur in a positive electrode to induce uniform electrodeposition/release of zinc, thereby inhibiting the growth of dendrites. Accordingly, reversibility is secured and thus electrochemical performance is improved. By using a metal ion additive with a higher standard reduction potential than that of zinc and a lower standard oxidation potential than that of bromine, the metal ion may not react during battery operation, resulting in maintenance of battery performance.
[0071] The present inventive concept may prevent a crossover phenomenon of bromine using a bromine complexing agent, and thus bock a reaction with zinc as a negative electrode active material. Due to this, dendrite formation may be inhibited, and as a result, self-discharge of the electrolyte may be inhibited during charging.
[0072] Since the present inventive concept provides an aqueous non-flow zinc-bromine battery, there is no need to use an additional electrolyte tank, so the problem of pipe corrosion may not occur.
[0073] In the present inventive concept, as a commercially-available metal ion additive and bromine complexing agent are added to an electrolyte, and a membrane and a tank are not used, a manufacturing process may be simplified, and production costs may be reduced.
[0074] Example embodiments of the present inventive concept can inhibit dendrite growth by inducing uniform electrodeposition/release of zinc due to an electrostatic shielding phenomenon occurring at a negative electrode by using a metal ion additive. Accordingly, reversibility is secured to improve electrochemical performance. In addition, by using a metal ion additive which has a higher standard reduction potential than that of zinc and a lower standard oxidation potential than that of bromine, the metal ions do not react during battery operation, so battery performance can be maintained.
[0075] Example embodiments of the present inventive concept can prevent a crossover phenomenon of bromine using a bromine complexing agent without a membrane, preventing a reaction with zinc, which is a negative electrode active material. Accordingly, coulombic efficiency can be increased by inhibiting dendrite formation, resulting in inhibition of self-discharge of the electrolyte during charging.
[0076] Example embodiments of the present inventive concept relate to an aqueous non-flow zinc-bromine battery, and thus, there is no need to additionally use an electrolyte tank, so the problem of piping corrosion does not occur.
[0077] Example embodiments of the present inventive concept can simplify a manufacturing process and reduce costs by inputting a commercially-available metal ion additive and bromine complexing agent to an electrolyte without using a membrane and a tank.